Ph: 207.396.6433 Fx: 207.396.6436
51 US Route 1 Suite H Scarborough, ME 04074
MetabolicLeader Logo

Metabolic Leader
We specialize in the diagnosis, treatment, and prevention of metabolic disorders of the endocrine system. Opened on November 15, 2010 by Dr. Stephan Babirak to provide the highest quality patient – focused healthcare in the southern Maine region.

LipidologyEndocrinologyApheresisDiabetesEducationResearch

We are now located at
51 US Route 1, Suite H Scarborough, ME 04074

Our Hours

Monday - Thursday
Office Hours:
8:00am – 4:00pm
Phone Hours:
9:00am – 4:00pm
Closed for lunch:
12:00 – 1:00pm
Closed on Friday

Healthy Food, Healthy You!

Eat healthy & get fit with these helpful tips.

APHERESIS Apheresis Video

View our video promoting a higher quality of life through Apheresis.

Are you at Risk for Diabetes?

To Buy Azithromycin Online Visit Our Pharmacy ↓




Common Uses of Azithromycin in Modern Medicine

Treating Respiratory Tract Infections Effectively


Azithromycin, a powerful macrolide antibiotic, plays a crucial role in battling a variety of respiratory tract infections. Its broad-spectrum activity makes it an ideal choice for conditions such as bronchitis, pneumonia, and sinusitis. By targeting bacterial protein synthesis, azithromycin eradicates the pathogens, providing quick relief from symptoms. The medication’s long half-life allows for shorter treatment durations, which is highly beneficial for patient compliance. Unlike other antibiotics, azithromycin demonstrates excellent penetration into respiratory tissues, ensuring more effective treatment outcomes. Here is a brief overview of some common respiratory infections treated with azithromycin:

Infection Typical Symptoms
Bronchitis Cough, shortness of breath, chest discomfort
Pneumonia Fever, chills, chest pain, productive cough
Sinusitis Facial pain, nasal congestion, headache

Overall, azithromycin’s efficacy, along with its favorable dosing regimen, makes it a significantly effective option for treating respiratory tract infections.



Combatting Skin and Soft Tissue Infections



Azithromycin has become a cornerstone in treating various skin and soft tissue infections, proving its versatility and effectiveness. This macrolide antibiotic works by inhibiting bacterial protein synthesis, thus halting microbial growth and aiding rapid recovery. From cellulitis to impetigo, azithromycin offers a robust defense against a spectrum of bacterial pathogens commonly associated with skin-related ailments. Its once-daily dosing and shorter treatment courses are particularly advantageous, ensuring compliance and enhancing patient outcomes.

Additionally, azithromycin's anti-inflammatory properties contribute to reducing redness and swelling, providing symptomatic relief. This dual action makes it particularly beneficial in complex bacterial infections, accelerating the healing process and minimizing potential complications. The medication's bioavailability and tissue penetration are key factors that contribute to its effectiveness, ensuring it targets the infected area efficiently for optimal results.



Managing Sexually Transmitted Infections


Azithromycin has become a cornerstone in the treatment of sexually transmitted infections (STIs) due to its broad-spectrum antibacterial properties. It is highly effective against common pathogens like Chlamydia trachomatis and Neisseria gonorrhoeae. A single dose of azithromycin is often sufficient to eradicate these infections, simplifying the treatment regimen and improving patient compliance.

In addition to its efficacy, azithromycin is well-tolerated, with fewer gastrointestinal side effects compared to other antibiotics. This makes it a suitable option for a diverse range of patients, including those who may experience difficulties with more aggressive treatments. Its use in managing STIs has significantly contributed to public health efforts in controlling the spread of these infections.

Moreover, azithromycin’s ability to be administered as a single-dose treatment enhances its practicality in high-risk populations and low-resource settings. This efficiency not only benefits the individual but also aids in reducing the overall transmission rates of sexually transmitted infections.



Addressing Ear Infections in Pediatric Patients



Children are particularly susceptible to ear infections, which can be both painful and disruptive to their daily lives. Azithromycin has become a preferred choice for treating these infections due to its broad-spectrum antibacterial properties and convenient dosing schedule. Its efficacy in reducing the symptoms and duration of ear infections helps in minimizing discomfort and preventing complications that may arise from untreated conditions.

Pediatricians often opt for azithromycin because of its safety profile and reduced side effects, making it easier for parents to administer to young children. The medication’s ability to penetrate ear tissues and exert a sustained effect ensures a quicker recovery and fewer follow-up visits, offering peace of mind to worried parents.



Treating Gastrointestinal Infections Like Typhoid



Azithromycin has become a cornerstone in treating gastrointestinal infections, largely due to its effectiveness against bacteria like Salmonella typhi, the culprit behind typhoid fever. By inhibiting bacterial protein synthesis, this antibiotic rapidly mitigates the symptoms and curtails the spread of infection, offering a faster recovery period compared to traditional treatments. It's especially valuable in regions where antibiotic resistance poses significant challenges, making it a reliable and widely adopted choice.

Benefits Details
Efficiency Rapidly mitigates symptoms
Action Mechanism Inhibits bacterial protein synthesis
Resistance Management Effective in regions with high antibiotic resistance

This makes azithromycin not only an effective but also a strategic choice in various medical settings. By using this antibiotic, healthcare providers can better manage patient outcomes and reduce the public health burden of typhoid fever.



Prophylactic Use in Patients with Hiv/aids


HIV/AIDS patients often face a compromised immune system, making them more susceptible to opportunistic infections. One crucial measure to protect these patients is the use of azithromycin as a prophylactic treatment, which helps prevent the onset of bacterial infections. By reducing the bacterial load in the body, azithromycin significantly lowers the risk of conditions such as Mycobacterium avium complex (MAC) disease. This proactive approach is especially important in managing the health of HIV/AIDS patients, who are at high risk for severe infections. Regular, monitored administration of azithromycin provides an added layer of defense, enhancing overall patient outcomes and quality of life.